Related references
Note: Only part of the references are listed.Antibiotic development - economic, regulatory and societal challenges
Christine Ardal et al.
NATURE REVIEWS MICROBIOLOGY (2020)
Current trends in the pharmacological management of Chagas disease
Vanessa Ribeiro et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2020)
Preclinical Gold Complexes as Oral Drug Candidates to Treat Leishmaniasis Are Potent Trypanothione Reductase Inhibitors
Luiza G. Tunes et al.
ACS INFECTIOUS DISEASES (2020)
High-Throughput Screening of the ReFRAME Library Identifies Potential Drug Repurposing Candidates for Trypanosoma cruzi
Jean A. Bernatchez et al.
MICROORGANISMS (2020)
Development of Leishmania (Mundinia) in guinea pigs
Tomas Becvar et al.
PARASITES & VECTORS (2020)
The relevance of persisters in tuberculosis drug discovery
Soma Mandal et al.
MICROBIOLOGY-SGM (2019)
RNA-Seq Revealed Expression of Many Novel Genes Associated With Leishmania donovani Persistence and Clearance in the Host Macrophage
Mohammad Shadab et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
Leishmania infantum -Tubulin Identified by Reverse Engineering Technology through Phage Display Applied as Theranostic Marker for Human Visceral Leishmaniasis
Lourena E. Costa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition
Susan Wyllie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Envisioning the innovations in nanomedicine to combat visceral leishmaniasis: for future theranostic application
Om Prakash Singh et al.
NANOMEDICINE (2019)
Genetic dissection of a Leishmania flagellar proteome demonstrates requirement for directional motility in sand fly infections
Tom Beneke et al.
PLOS PATHOGENS (2019)
Pharmacometabolomics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis
Deninson Alejandro Vargas et al.
FRONTIERS IN PHARMACOLOGY (2019)
Chagas Disease: From Discovery to a Worldwide Health Problem
Karita Claudia Freitas Lidani et al.
FRONTIERS IN PUBLIC HEALTH (2019)
Advances in preclinical approaches to Chagas disease drug discovery
Fernando Villalta et al.
EXPERT OPINION ON DRUG DISCOVERY (2019)
Metabolomics, lipidomics and proteomics profiling of myoblasts infected with Trypanosoma cruzi after treatment with different drugs against Chagas disease
K. Hennig et al.
METABOLOMICS (2019)
Protozoan persister-like cells and drug treatment failure
Michael P. Barrett et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Post-Kala-Azar Dermal Leishmaniasis as a Reservoir for Visceral Leishmaniasis Transmission
Epke A. Le Rutte et al.
TRENDS IN PARASITOLOGY (2019)
Measuring mitochondrial respiration in adherent cells infected with Trypanosoma cruzi Chagas, 1909 using Seahorse extracellular flux analyser
Laura Maria Gonzalez-Ortiz et al.
FOLIA PARASITOLOGICA (2019)
000Synthesis of new α-aminophosphonates: Evaluation as anti-inflammatory agents and QSAR studies
Ivan Romero-Estudillo et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Immuno-metabolic profile of human macrophages after Leishmania and Trypanosoma cruzi infection
Maureen C. Ty et al.
PLOS ONE (2019)
Coupling chemical mutagenesis to next generation sequencing for the identification of drug resistance mutations in Leishmania
Arijit Bhattacharya et al.
NATURE COMMUNICATIONS (2019)
Tracking of quiescence in Leishmania by quantifying the expression of GFP in the ribosomal DNA locus
Marlene Jara et al.
SCIENTIFIC REPORTS (2019)
Phenotypic screening approaches for Chagas disease drug discovery
Eric Chatelain et al.
EXPERT OPINION ON DRUG DISCOVERY (2018)
An overview on Leishmania (Mundinia) enriettii: biology, immunopathology, LRV and extracellular vesicles during the host-parasite interaction
Larissa F. Paranaiba et al.
PARASITOLOGY (2018)
Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8CTE inhibitors as potential therapeutics for leishmaniasis
Laura De Luca et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2018)
Fluorine walk: The impact of fluorine in quinolone amides on their activity against African sleeping sickness
Michael Berninger et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
In Silico Discovery of a Substituted 6-Methoxy-quinalidine with Leishmanicidal Activity in Leishmania infantum
Strahinja Stevanovic et al.
MOLECULES (2018)
Oxidative Stress-Mediated Overexpression of Uracil DNA Glycosylase in Leishmania donovani Confers Tolerance against Antileishmanial Drugs
Anshul Mishra et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Trypanosomatids Are Much More than Just Trypanosomes: Clues from the Expanded Family Tree
Julius Lukes et al.
TRENDS IN PARASITOLOGY (2018)
Quantitative and histological assessment of maternal-fetal transmission of Trypanosoma cruzi in guinea pigs: An experimental model of congenital Chagas disease
Jatziri Torres-Vargas et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Experimental Chagas disease-induced perturbations of the fecal microbiome and metabolome
Laura-Isobel McCall et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas' disease drug discovery
Lorna M. MacLean et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure
Fernando J. Sanchez-Valdez et al.
ELIFE (2018)
High-throughput Cos-Seq screen with intracellular Leishmania infantum for the discovery of novel drug-resistance mechanisms
Christopher Fernandez-Prada et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2018)
In vitro and in vivo pharmacodynamics of three novel antileishmanial lead series
M. Van den Kerkhof et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2018)
Molecular Preadaptation to Antimony Resistance in Leishmania donovani on the Indian Subcontinent
F. Dumetz et al.
MSPHERE (2018)
Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis
Susan Wyllie et al.
NATURE (2018)
Importance of secondary screening with clinical isolates for anti-leishmania drug discovery
Aya Hefnawy et al.
SCIENTIFIC REPORTS (2018)
Insights into antitrypanosomal drug mode-of-action from cytology-based profiling
James Thomas et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Repurposing of an old drug: In vitro and in vivo efficacies of buparvaquone against Echinococcus multilocularis
Reto Rufener et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2018)
Treatment of Chagas Disease in the United States
Sheba Meymandi et al.
CURRENT TREATMENT OPTIONS IN INFECTIOUS DISEASES (2018)
Drug repurposing screens and synergistic drug-combinations for infectious diseases
Wei Zheng et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Murine models susceptibility to distinct Trypanosoma cruzi I genotypes infection
Cielo M. Leon et al.
PARASITOLOGY (2017)
Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need
Mark C. Field et al.
NATURE REVIEWS MICROBIOLOGY (2017)
Persistent bacterial infections and persister cells
Robert A. Fisher et al.
NATURE REVIEWS MICROBIOLOGY (2017)
The evolution of trypanosomatid taxonomy
Alexa Kaufer et al.
PARASITES & VECTORS (2017)
Macromolecular biosynthetic parameters and metabolic profile in different life stages of Leishmania braziliensis: Amastigotes as a functionally less active stage
Marlene Jara et al.
PLOS ONE (2017)
Continual renewal and replication of persistent Leishmania major parasites in concomitantly immune hosts
Michael A. Mandell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Malaria Eradication and the Hidden Parasite Reservoir
Miles B. Markus
TRENDS IN PARASITOLOGY (2017)
An insight into tetrahydro-β-carboline-tetrazole hybrids: synthesis and bioevaluation as potent antileishmanial agents
Pooja Purohit et al.
MEDCHEMCOMM (2017)
Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress
Deepak Kumar Deep et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Global urbanization and the neglected tropical diseases
Peter J. Hotez
PLOS NEGLECTED TROPICAL DISEASES (2017)
Host triacylglycerols shape the lipidome of intracellular trypanosomes and modulate their growth
Felipe Gazos-Lopes et al.
PLOS PATHOGENS (2017)
Characterisation of Casein Kinase 1.1 in Leishmania donovani Using the CRISPR Cas9 Toolkit
Daniel Martel et al.
BIOMED RESEARCH INTERNATIONAL (2017)
A CRISPR Cas9 high-throughput genome editing toolkit for kinetoplastids
Tom Beneke et al.
ROYAL SOCIETY OPEN SCIENCE (2017)
Mass Spectrometry-Based Chemical Cartography of a Cardiac Parasitic Infection
Laura-Isobel McCall et al.
ANALYTICAL CHEMISTRY (2017)
In Vitro Sensitivity of Cutaneous Leishmania Promastigote Isolates Circulating in French Guiana to a Set of Drugs
Marine Ginouves et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2017)
Combinatorial chemistry in drug discovery
Ruiwu Liu et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2017)
A Replicative In Vitro Assay for Drug Discovery against Leishmania donovani
Diana Tegazzini et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Integrating biophysics with HTS-driven drug discovery projects
Rutger H. A. Folmer
DRUG DISCOVERY TODAY (2016)
Structure based medicinal chemistry-driven strategy to design substituted dihydropyrimidines as potential antileishmanial agents
Umer Rashid et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Bioenergetic profiling of Trypanosoma cruzi life stages using Seahorse extracellular flux technology
Sheena Shah-Simpson et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2016)
Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
Shilpi Khare et al.
NATURE (2016)
Study of Leishmania pathogenesis in mice: experimental considerations
Corinne Loeuillet et al.
PARASITES & VECTORS (2016)
Cos-Seq for high-throughput identification of drug target and resistance mechanisms in the protozoan parasite Leishmania
Elodie Gazanion et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
A Multilayer Network Approach for Guiding Drug Repositioning in Neglected Diseases
Ariel Jose Berenstein et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Phenotypic Features of Circulating Leukocytes from Non-human Primates Naturally Infected with Trypanosoma cruzi Resemble the Major Immunological Findings Observed in Human Chagas Disease
Renato Sathler-Avelar et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Different Mutations in a P-type ATPase Transporter in Leishmania Parasites are Associated with Cross-resistance to Two Leading Drugs by Distinct Mechanisms
Christopher Fernandez-Prada et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Identification of Trypanocidal Activity for Known Clinical Compounds Using a New Trypanosoma cruzi Hit-Discovery Screening Cascade
Manu De Rycker et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Transcriptome Remodeling in Trypanosoma cruzi and Human Cells during Intracellular Infection
Yuan Li et al.
PLOS PATHOGENS (2016)
Chemometrics tools in QSAR/QSPR studies: A historical perspective
Saeed Yousefinejad et al.
CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS (2015)
Trypanosomatids see the light: recent advances in bioimaging research
Estefania Calvo-Alvarez et al.
DRUG DISCOVERY TODAY (2015)
Novel Amino-pyrazole Ureas with Potent In Vitro and In Vivo Antileishmanial Activity
Charles E. Mowbray et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Theranostic applications of phage display to control leishmaniasis: selection of biomarkers for serodiagnostics, vaccination, and immunotherapy
Eduardo Antonio Ferraz Coelho et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2015)
New Compound Sets Identified from High Throughput Phenotypic Screening Against Three Kinetoplastid Parasites: An Open Resource
Imanol Pena et al.
SCIENTIFIC REPORTS (2015)
A Pre-clinical Animal Model of Trypanosoma brucei Infection Demonstrating Cardiac Dysfunction
Charlotte S. McCarroll et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Automated High-Content Assay for Compounds Selectively Toxic to Trypanosoma cruzi in a Myoblastic Cell Line
Julio Alonso-Padilla et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis
Emily Rose Mears et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Characterization of Metabolically Quiescent Leishmania Parasites in Murine Lesions Using Heavy Water Labeling
Joachim Kloehn et al.
PLOS PATHOGENS (2015)
Genome-scale RNAi screens for high-throughput phenotyping in bloodstream-form African trypanosomes
Lucy Glover et al.
NATURE PROTOCOLS (2015)
A Multiplatform Metabolomic Approach to the Basis of Antimonial Action and Resistance in Leishmania infantum
David Rojo et al.
PLOS ONE (2015)
Metabolomic-Based Strategies for Anti-Parasite Drug Discovery
Isabel M. Vincent et al.
JOURNAL OF BIOMOLECULAR SCREENING (2015)
Drug Discovery for Human African Trypanosomiasis: Identification of Novel Scaffolds by the Newly Developed HTS SYBR Green Assay for Trypanosoma brucei
Joana Faria et al.
JOURNAL OF BIOMOLECULAR SCREENING (2015)
Towards a Paradigm Shift in the Treatment of Chronic Chagas Disease
R. Viotti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
A canine model of experimental infection with Leishmania (L.) mexicana
Julio Vladimir Cruz-Chan et al.
PARASITES & VECTORS (2014)
ANIMAL MODELS FOR THE STUDY OF LEISHMANIASIS IMMUNOLOGY
Elsy Nalleli Loria-Cervera et al.
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO (2014)
Genome-Wide Stochastic Adaptive DNA Amplification at Direct and Inverted DNA Repeats in the Parasite Leishmania
Jean-Michel Ubeda et al.
PLOS BIOLOGY (2014)
Epidemiology of Visceral Leishmaniasis in Georgia
Giorgi Babuadze et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Visceral Leishmaniasis Outbreak in South Sudan 2009-2012: Epidemiological Assessment and Impact of a Multisectoral Response
Abdinasir Abubakar et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Benznidazole Biotransformation and Multiple Targets in Trypanosoma cruzi Revealed by Metabolomics
Andrea Trochine et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Metabolomics Guides Rational Development of a Simplified Cell Culture Medium for Drug Screening against Trypanosoma brucei
Darren J. Creek et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Comparison of a High-Throughput High-Content Intracellular Leishmania donovani Assay with an Axenic Amastigote Assay
Manu De Rycker et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Gimatecan and other camptothecin derivatives poison Leishmania DNA-topoisomerase IB leading to a strong leishmanicidal effect
Christopher F. Prada et al.
BIOCHEMICAL PHARMACOLOGY (2013)
An outbreak investigation of visceral leishmaniasis among residents of Dharan town, eastern Nepal, evidence for urban transmission of Leishmania donovani
Surendra Uranw et al.
BMC INFECTIOUS DISEASES (2013)
Re-emergence of leishmaniasis in Spain: community outbreak in Madrid, Spain, 2009 to 2012
A. Arce et al.
EUROSURVEILLANCE (2013)
Global economic burden of Chagas disease: a computational simulation model
Bruce Y. Lee et al.
LANCET INFECTIOUS DISEASES (2013)
A Novel Integrated Method for Large-Scale Detection, Identification, and Quantification of Widely Targeted Metabolites: Application in the Study of Rice Metabolomics
Wei Chen et al.
MOLECULAR PLANT (2013)
Cell death in parasitic protozoa: regulated or incidental?
William R. Proto et al.
NATURE REVIEWS MICROBIOLOGY (2013)
TDP1 is an HMG chromatin protein facilitating RNA polymerase I transcription in African trypanosomes
Mani Shankar Narayanan et al.
NUCLEIC ACIDS RESEARCH (2013)
Genetic dissection of drug resistance in trypanosomes
Sam Alsford et al.
PARASITOLOGY (2013)
Golden hamster (Mesocricetus auratus) as an experimental model for Leishmania (Viannia) braziliensis infection
Adriano Gomes-Silva et al.
PARASITOLOGY (2013)
Proteomic and Genomic Analyses of Antimony Resistant Leishmania infantum Mutant
Marie-Christine Brotherton et al.
PLOS ONE (2013)
Challenges and opportunities of drug repositioning.
Natalia Novac
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
High Content Analysis of Primary Macrophages Hosting Proliferating Leishmania Amastigotes: Application to Anti-leishmanial Drug Discovery
Nathalie Aulner et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Indotecan (LMP400) and AM13-55: Two Novel Indenoisoquinolines Show Potential for Treating Visceral Leishmaniasis
Rafael Balana-Fouce et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis
Thomas P. C. Dorlo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Trypanosomal histone γH2A and the DNA damage response
Lucy Glover et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2012)
High-throughput decoding of antitrypanosomal drug efficacy and resistance
Sam Alsford et al.
NATURE (2012)
Trypanosomal immune evasion, chronicity and transmission: an elegant balancing act
Paula MacGregor et al.
NATURE REVIEWS MICROBIOLOGY (2012)
Functional Characterization of 8-Oxoguanine DNA Glycosylase of Trypanosoma cruzi
Carolina Furtado et al.
PLOS ONE (2012)
Aquaglyceroporin 2 controls susceptibility to melarsoprol and pentamidine in African trypanosomes
Nicola Baker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Identification of Compounds with Anti-Proliferative Activity against Trypanosoma brucei brucei Strain 427 by a Whole Cell Viability Based HTS Campaign
Melissa L. Sykes et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
The immunobiology of Leishmania braziliensis infection
Camila I. de Oliveira et al.
FRONTIERS IN IMMUNOLOGY (2012)
Drug discovery for neglected tropical diseases at the Sandler Center
Stephanie A. Robertson et al.
FUTURE MEDICINAL CHEMISTRY (2011)
High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome
Sam Alsford et al.
GENOME RESEARCH (2011)
In situ characterization of the granulomatous immune response with time in nonhealing lesional skin of Leishmania braziliensis-infected rhesus macaques (Macaca mulatta)
Camila Souza-Lemos et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2011)
SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis
Robert T. Jacobs et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Identification of Small Molecule Lead Compounds for Visceral Leishmaniasis Using a Novel Ex Vivo Splenic Explant Model System
Yaneth Osorio et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Trypanocidal Activity of Aziridinyl Nitrobenzamide Prodrugs
Chris Bot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Image-Based High-Throughput Drug Screening Targeting the Intracellular Stage of Trypanosoma cruzi, the Agent of Chagas' Disease
Juan C. Engel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent
Karin Seifert et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
In Vitro and In Vivo High-Throughput Assays for the Testing of Anti-Trypanosoma cruzi Compounds
Adriana M. C. Canavaci et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Fexinidazole - A New Oral Nitroimidazole Drug Candidate Entering Clinical Development for the Treatment of Sleeping Sickness
Els Torreele et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
In Vitro Susceptibilities of Leishmania donovani Promastigote and Amastigote Stages to Antileishmanial Reference Drugs: Practical Relevance of Stage-Specific Differences
Marieke Vermeersch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Trypanocidal drugs: mechanisms, resistance and new targets
Shane R. Wilkinson et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)
A new approach for potential drug target discovery through in silico metabolic pathway analysis using Trypanosoma cruzi genome information
Marcelo Alves-Ferreira et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2009)
A luciferase based viability assay for ATP detection in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427
Melissa L. Sykes et al.
PARASITES & VECTORS (2009)
Advances in measuring cellular bioenergetics using extracellular flux
David A. Ferrick et al.
DRUG DISCOVERY TODAY (2008)
Comparison of the expression profiles of promastigotes and axenic amastigotes in Leishmania donovani using serial analysis of gene expression
Qiaoli Li et al.
PARASITOLOGY RESEARCH (2008)
Evaluation and treatment of Chagas disease in the United States - A systematic review
Caryn Bern et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei
Zachary B. Mackey et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2006)
Modulation in aquaglyceroporin AQP1 gene transcript levels in drug-resistant Leishmania
N Marquis et al.
MOLECULAR MICROBIOLOGY (2005)
Fossil evidence of insect pathogens
G Poinar et al.
JOURNAL OF INVERTEBRATE PATHOLOGY (2005)
Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection)
P. A. Reyes et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2005)
New approaches to the microscopic imaging of Trypanosoma brucei
MC Field et al.
MICROSCOPY AND MICROANALYSIS (2004)
New drugs for neglected diseases:: From pipeline to patients
B Pécoul
PLOS MEDICINE (2004)
Antimony uptake systems in the protozoan parasite Leishmania and accumulation differences in antimony-resistant parasites
C Brochu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Immunological and pathological evaluation of rhesus macaques infected with Leishmania major
BL Freidag et al.
EXPERIMENTAL PARASITOLOGY (2003)
The price of innovation: new estimates of drug development costs
JA DiMasi et al.
JOURNAL OF HEALTH ECONOMICS (2003)
Rhesus monkey model for Leishmania major transmitted by Phlebotomus papatasi sandfly bites
RJ Probst et al.
MEDICAL AND VETERINARY ENTOMOLOGY (2001)
In vitro cultivation and characterization of axenic amastigotes of Leishmania
N Gupta et al.
TRENDS IN PARASITOLOGY (2001)
Share Paper
